100 related articles for article (PubMed ID: 26775546)
1. The Use and Misuse of ACE Inhibitors in Patients with Single Ventricle Physiology.
Wilson TG; Iyengar AJ; d'Udekem Y
Heart Lung Circ; 2016 Mar; 25(3):229-36. PubMed ID: 26775546
[TBL] [Abstract][Full Text] [Related]
2. Use of ACE inhibitors in Fontan: Rational or irrational?
Wilson TG; Iyengar AJ; Winlaw DS; Weintraub RG; Wheaton GR; Gentles TL; Ayer J; Grigg LE; Justo RN; Radford DJ; Bullock A; Celermajer DS; Dalziel K; Schilling C; d'Udekem Y;
Int J Cardiol; 2016 May; 210():95-9. PubMed ID: 26938683
[TBL] [Abstract][Full Text] [Related]
3. Effect of anti-heart failure therapy on diastolic function in children with single-ventricle circulations.
Yim DL; Jones BO; Alexander PM; d'Udekem Y; Cheung MM
Cardiol Young; 2015 Oct; 25(7):1293-9. PubMed ID: 25739738
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibitors for intermittent claudication associated with peripheral arterial disease.
Hunter MR; Cahoon WD; Lowe DK
Ann Pharmacother; 2013 Nov; 47(11):1552-7. PubMed ID: 24285767
[TBL] [Abstract][Full Text] [Related]
5. Rationale and design of a trial of angiotensin-converting enzyme inhibition in infants with single ventricle.
Hsu DT; Mital S; Ravishankar C; Margossian R; Li JS; Sleeper LA; Williams RV; Levine JC; McCrindle BW; Atz AM; Servedio D; Mahony L;
Am Heart J; 2009 Jan; 157(1):37-45. PubMed ID: 19081394
[TBL] [Abstract][Full Text] [Related]
6. Safety of Angiotensin-converting enzyme inhibitors in patients with insect venom allergies.
Stumpf JL; Shehab N; Patel AC
Ann Pharmacother; 2006 Apr; 40(4):699-703. PubMed ID: 16569814
[TBL] [Abstract][Full Text] [Related]
7. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
8. Role of angiotensin-converting enzyme inhibitors in vascular modulation: beyond the hypertensive effects.
Katragadda S; Arora RR
Am J Ther; 2010; 17(1):e11-23. PubMed ID: 20090429
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficiency of chronic ACE inhibition in symptomatic heart failure patients with a systemic right ventricle.
Tutarel O; Meyer GP; Bertram H; Wessel A; Schieffer B; Westhoff-Bleck M
Int J Cardiol; 2012 Jan; 154(1):14-6. PubMed ID: 20843567
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic characteristics of cyanotic adults with single-ventricle physiology without Fontan completion.
Saab FG; Aboulhosn JA
Congenit Heart Dis; 2013; 8(2):124-30. PubMed ID: 22891795
[TBL] [Abstract][Full Text] [Related]
11. Mortality benefit of angiotensin-converting enzyme inhibitors after cardiac events in patients with end-stage renal disease.
McCullough PA; Sandberg KR; Yee J; Hudson MP
J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3(3):188-91. PubMed ID: 12563570
[TBL] [Abstract][Full Text] [Related]
12. [Angiotensin converting enzyme inhibitors for hypertension].
Kobusiak-Prokopowicz M
Pol Merkur Lekarski; 1997 Jan; 2(7):66-70. PubMed ID: 9296907
[TBL] [Abstract][Full Text] [Related]
13. Failure to practice evidence-based medicine: why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors?
McMurray JJ
Eur Heart J; 1998 Oct; 19 Suppl L():L15-21. PubMed ID: 9821004
[TBL] [Abstract][Full Text] [Related]
14. Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on risk of atrial fibrillation before coronary artery bypass grafting.
Johnston K; Stephens S
Ann Pharmacother; 2012 Sep; 46(9):1239-44. PubMed ID: 22947592
[TBL] [Abstract][Full Text] [Related]
15. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. The Large State Peer Review Organization Consortium.
Arch Intern Med; 1997 May; 157(10):1103-8. PubMed ID: 9164376
[TBL] [Abstract][Full Text] [Related]
16. Translating clinical trials into clinical practice: a survey assessing the potential impact of the Pediatric Heart Network Infant Single Ventricle Trial.
Zak V; Hsu DT; Pemberton VL; Levine JC; Atz AM; Cnota JF; Ravishankar C; Barker P; Lambert LM; McCrindle BW; Frommelt MA; Altmann K; Chen S; Williams RV;
Cardiol Young; 2017 Sep; 27(7):1265-1270. PubMed ID: 28183375
[TBL] [Abstract][Full Text] [Related]
17. The single-ventricle patient population: a current and future concern a population-based study in the North of England.
Coats L; O'Connor S; Wren C; O'Sullivan J
Heart; 2014 Sep; 100(17):1348-53. PubMed ID: 24794141
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.
Epstein BJ; Gums JG
Ann Pharmacother; 2005 Mar; 39(3):470-80. PubMed ID: 15701766
[TBL] [Abstract][Full Text] [Related]
19. Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation.
Jennings DL; Taber DJ
Ann Pharmacother; 2008 Jan; 42(1):116-20. PubMed ID: 18094340
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the renin-angiotensin-aldosterone system and cough.
Lacourcière Y; Lefebvre J
Can J Cardiol; 1995 Aug; 11 Suppl F():33F-39F. PubMed ID: 7664216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
